C12Y 304/22004
Bromelain
Official title: Bromelain (3.4.22.4) (C12Y304/22032, C12Y304/22033 take precedence)
C12Y304/22004 (Bromelain) appears on 21 US grants and 40 published applications in this corpus.
Search patents in C12Y- Granted patents
- 21
- Published applications
- 40
- Assignees
- 24
- Inventors
- 86
- Latest grant
- 23 Dec 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1987 | 1 | 0 |
| 1988 | 0 | 0 |
| 1989 | 2 | 0 |
| 1990 | 0 | 0 |
| 1991 | 0 | 0 |
| 1992 | 1 | 0 |
| 1993 | 0 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 1 | 0 |
| 1997 | 0 | 0 |
| 1998 | 0 | 0 |
| 1999 | 0 | 0 |
| 2000 | 1 | 0 |
| 2001 | 1 | 0 |
| 2002 | 0 | 0 |
| 2003 | 2 | 1 |
| 2004 | 0 | 0 |
| 2005 | 0 | 0 |
| 2006 | 0 | 0 |
| 2007 | 0 | 1 |
| 2008 | 0 | 1 |
| 2009 | 0 | 0 |
| 2010 | 0 | 0 |
| 2011 | 0 | 1 |
| 2012 | 0 | 0 |
| 2013 | 0 | 3 |
| 2014 | 0 | 0 |
| 2015 | 0 | 1 |
| 2016 | 0 | 1 |
| 2017 | 1 | 2 |
| 2018 | 2 | 3 |
| 2019 | 0 | 2 |
| 2020 | 2 | 3 |
| 2021 | 2 | 2 |
| 2022 | 0 | 2 |
| 2023 | 1 | 4 |
| 2024 | 1 | 3 |
| 2025 | 3 | 8 |
| 2026 | 0 | 2 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Implantable device for sustained release of a macromolecular drug compound23 Dec 2025US 12,502,360 B2Celanese EVA Performance Polymers LLC
- Proteolytic enzyme composition18 Nov 2025US 12,472,242 B2Bright Lifecare Pvt. Ltd
- Proteolytic enzyme composition11 Feb 2025US 12,220,447 B2Bright Lifecare Pvt. Ltd
- Implantable device for sustained release of a macromolecular drug compound9 Apr 2024US 11,951,215 B2Celanese EVA Performance Polymers LLC
- Implantable device for sustained release of a macromolecular drug compound4 Jul 2023US 11,690,807 B2Celanese EVA Performance Polymers LLC
- Implantable Device for Sustained Release of a Macromolecular Drug Compound23 Jul 2026US 2026/0207523 A1Celanese EVA Performance Polymers LLC
- Methods of relieving pain21 May 2026US 2026/0137743 A1Infinitum Health, LLC
- Bio-optimized nutraceutical dietary supplement20 Nov 2025US 2025/0352503 A1
- Compositions for breakdown of gluten proteins28 Aug 2025US 2025/0268995 A1
- Topical Formulations for Reducing Bruising and/or Pain21 Aug 2025US 2025/0262285 A1
Most cited
By later US patents
- Dietary supplement and method for use as a probiotic, for alleviating the symptons associated with irritable bowel syndrome71US 6,203,797 B12001
- Topical anti-inflammatory composition and method26US 5,560,910 A1996
- Amine-functionalized polymeric compositions for medical devices21US 10,688,217 B2KCI Licensing, Inc. · 2020
- Process for the manufacture of novel coffee flavorants14US 5,130,149 AGivaudan SA · 1992
- Method for treating aqueous solution of soybean protein with enzymes11US 4,687,739 AHouse Food Industries Co., Ltd. · 1987